AI MARKET SCANNING

Arcutis Biotherapeutics, Inc.

AVG HISTORICAL GAP +5.04%
MAX GAP RECORD +15.87%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ARQT
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Oct 27, 2026 Earnings Release 2026-10-27 (AFTER CLOSE (16:00))
-0.57%
Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE)
+7.79%
May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE)
-5.59%
Feb 25, 2026 Earnings Release 2026-02-25 (AFTER CLOSE)
+2.52%
Oct 28, 2025 Earnings Release 2025-10-28 (BEFORE OPEN)
+14.56%
Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE)
+5.92%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
-0.56%
Feb 25, 2025 Earnings Release 2025-02-25 (AFTER CLOSE)
+13.52%

VOLATILITY & GAP BIAS

AVG GAP MOVE 6.5%
Bullish Gaps (11)
Bearish Gaps (2)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ARQT

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 2609m +1.47%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗